CHI3L1 and breast carcinoma: Targeting of CAF-derived Chi3L1 had a similar effect in another transplantable model of breast cancer, and resulted in enhanced infiltration of CD8+ T cells and a shift in the tumor cytokine profile toward a Th1-type phenotype.